Literature DB >> 23917102

Optic neuritis and the evaluation of visual impairment in multiple sclerosis.

Robert A Bermel1, Laura J Balcer.   

Abstract

PURPOSE OF REVIEW: This review covers causes of visual impairment in multiple sclerosis (MS), differential diagnosis, and treatment. Emerging technologies are sometimes used in assessing the visual system and may require a neurologist's familiarity. The most common causes are emphasized and discussed in detail, including illustrative cases. RECENT
FINDINGS: The use of optical coherence tomography as both a clinical and research tool has advanced our understanding of how the afferent visual system is affected by MS.
SUMMARY: Optic neuritis remains one of the most common initial manifestations of MS, although a number of other causes of visual impairment are possible even in the patient with known MS. Some causes of visual impairment are consequences or complications of MS treatment and are particularly important to recognize. Low-contrast letter acuity and optical coherence tomography are techniques or tests emerging from the research arena that may inform care of the patient with MS and are important for the neurologist to be aware of.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23917102     DOI: 10.1212/01.CON.0000433282.00221.7e

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  4 in total

1.  Drawing on related knowledge to advance multiple sclerosis falls-prevention research.

Authors:  Michelle Ploughman; Nandini Deshpande; Amy E Latimer-Cheung; Marcia Finlayson
Journal:  Int J MS Care       Date:  2014

2.  Is the incidence of optic neuritis rising? Evidence from an epidemiological study in Barcelona (Spain), 2008-2012.

Authors:  E H Martínez-Lapiscina; E Fraga-Pumar; X Pastor; M Gómez; A Conesa; R Lozano-Rubí; B Sánchez-Dalmau; A Alonso; Pablo Villoslada
Journal:  J Neurol       Date:  2014-02-16       Impact factor: 4.849

3.  Effects of Contrast Sensitivity on Colour Vision Testing.

Authors:  Anvesh Annadanam; Jiawei Zhao; Jiangxia Wang; Allen O Eghrari
Journal:  Neuroophthalmology       Date:  2017-05-19

4.  Detection of aquaporin-4 antibodies for patients with CNS inflammatory demyelinating diseases other than typical MS in Lithuania.

Authors:  Eglė Sakalauskaitė-Juodeikienė; Giedrė Armalienė; Rasa Kizlaitienė; Loreta Bagdonaitė; Nataša Giedraitienė; Dalia Mickevičienė; Daiva Rastenytė; Gintaras Kaubrys; Dalius Jatužis
Journal:  Brain Behav       Date:  2018-10-03       Impact factor: 2.708

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.